SAN ANTONIO--The results of a study comparing whether Intraosseous (IO) vascular access may be used to infuse chilled saline as effectively as peripheral intravenous (IV) access to achieve therapeutic hypothermia found no statistical difference between the two routes. The findings were announced on January 12 at an oral presentation at the National Association of EMS Physicians 2012 Annual Meeting by Dr. Larry J. Miller and the Science and Clinical team from Vidacare Corporation, makers of the EZ-IO Intraosseous Infusion System.
The study, “Infusing Chilled Saline Through the Intraosseous Route is Equivalent to Infusion Through the Intravenous Route in Reducing the Core Temperature in Swine,” investigated whether Intraosseous (IO) vascular access may be effectively used to infuse chilled saline to achieve therapeutic hypothermia (TH) as an alternative to peripheral intravenous (IV) access. The study found that IO and IV temperature reductions were statistically equivalent and concluded that there was no clinical or statistical difference between IV and IO when comparing the two routes for infusion of chilled saline for therapeutic hypothermia.
SOURCE: EON: Enhanced Online News